Search Results - "Herman, Rok"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport by Herman, Rok, Kravos, Nika Aleksandra, Jensterle, Mojca, Janež, Andrej, Dolžan, Vita

    “…Metformin is the most commonly used treatment to increase insulin sensitivity in insulin-resistant (IR) conditions such as diabetes, prediabetes, polycystic…”
    Get full text
    Journal Article
  2. 2

    Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance by Herman, Rok, Sikonja, Jaka, Jensterle, Mojca, Janez, Andrej, Dolzan, Vita

    “…Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age. Its heterogeneous clinical presentation is…”
    Get full text
    Journal Article
  3. 3

    Sex- and Gender-Related Differences in Obesity: From Pathophysiological Mechanisms to Clinical Implications by Koceva, Andrijana, Herman, Rok, Janez, Andrej, Rakusa, Matej, Jensterle, Mojca

    “…Obesity, primarily characterized by excessive fat accumulation, is a multifactorial chronic disease with an increasing global prevalence. Despite the…”
    Get full text
    Journal Article
  4. 4

    Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity by Hropot, Tim, Herman, Rok, Janez, Andrej, Lezaic, Luka, Jensterle, Mojca

    “…Adipose tissue can be divided into white adipose tissue (WAT), brown adipose tissue (BAT), and beige adipose tissue, according to the differences in…”
    Get full text
    Journal Article
  5. 5

    Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives by Jensterle, Mojca, Herman, Rok, Janež, Andrej

    Published in Biomedicines (01-08-2022)
    “…Despite the continuous effort to understand the pathophysiology and determine potential therapeutic targets, PCOS treatment largely depends on lifestyle…”
    Get full text
    Journal Article
  6. 6

    The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date by Kolnikaj, Tea Shehu, Herman, Rok, Janež, Andrej, Jensterle, Mojca

    Published in Medicina (Kaunas, Lithuania) (01-01-2024)
    “…Polycystic ovary syndrome (PCOS) manifests a multifactorial pathology characterized by polycystic ovaries, menstrual cycle disorders, varying degrees of…”
    Get full text
    Journal Article
  7. 7

    Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome by Kolnikaj, Tea Shehu, Herman, Rok, Janež, Andrej, Jensterle, Mojca

    Published in Life (Basel, Switzerland) (01-11-2022)
    “…The essential role of the frequent coexistence of mental disorders and polycystic ovary syndrome (PCOS) is being increasingly recognized in the management of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects by Mastnak, Lara, Herman, Rok, Ferjan, Simona, Janež, Andrej, Jensterle, Mojca

    Published in Life (Basel, Switzerland) (01-10-2023)
    “…Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder in premenopausal women, characterized by hyperandrogenism, ovulatory…”
    Get full text
    Journal Article
  10. 10

    Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? by Jensterle, Mojca, Kravos, Nika Aleksandra, Dolžan, Vita, Goričar, Katja, Herman, Rok, Rizzo, Manfredi, Janež, Andrej

    Published in Endocrine (01-03-2022)
    “…Purpose Metformin induces GLUT-4 mRNA expression in insulin target tissues in PCOS. It is unclear how long this impact is sustained after withdrawal of…”
    Get full text
    Journal Article
  11. 11

    Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly by Herman, Rok, Janež, Andrej, Goričar, Katja, Rizzo, Manfredi, Jensterle, Mojca

    Published in Medicina (Kaunas, Lithuania) (23-11-2022)
    “…: Despite the best efforts of healthcare workers and the deployment of alternative healthcare delivery solutions through telemedicine, the pandemic has…”
    Get full text
    Journal Article
  12. 12

    Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome by Herman, Rok, Jensterle, Mojca, Janež, Andrej, Goričar, Katja, Dolžan, Vita

    Published in Metabolites (29-10-2020)
    “…Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder of multifactorial etiopathology likely to involve the interactions between…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Opredelitev povezanosti kakovosti življenja bolnikov z akromegalijo z biokemičnimi in kliničnimi značilnostmi njihove bolezni by Herman, Rok, Mastnak, Lara, Goričar, Katja, Janež, Andrej, Jensterle Sever, Mojca

    “…Background: The gap between the treatment goals for acromegaly as defined by clinicians and patients has contributed to developing new tools for a standardized…”
    Get full text
    Journal Article
  15. 15

    Opredelitev povezanosti kakovosti življenja bolnikov z akromegalijo z biokemičnimi in kliničnimi značilnostmi njihove bolezni by Rok Herman, Lara Mastnak, Katja Goričar, Andrej Janež, Mojca Jensterle Sever

    “…Izhodišča: Razkorak med cilji zdravljenja akromegalije, kot jih opredeljujejo zdravniki in bolniki, je prispeval k razvoju novih orodij za standardizirano…”
    Get full text
    Journal Article